CT works by activating the G-proteinsGs and Gq often found on osteoclasts, on cells in the kidney, and on cells in a number of regions of the brain.[9] It may also affect the ovaries in women and the testes in men.
The function of the CT receptor protein is modified through its interaction with Receptor activity-modifying proteins (RAMPs), forming the multimeric amylin receptors AMY1 (CT + RAMP1), AMY2 (CT + RAMP2), and AMY3 (CT+ RAMP3).[10]
"Calcitonin Receptors: Introduction". IUPHAR Database of Receptors and Ion Channels. International Union of Basic and Clinical Pharmacology. Archived from the original on 2016-03-03. Retrieved 2008-12-12.
Albrandt K, Brady EM, Moore CX, Mull E, Sierzega ME, Beaumont K (December 1995). "Molecular cloning and functional expression of a third isoform of the human calcitonin receptor and partial characterization of the calcitonin receptor gene". Endocrinology. 136 (12): 5377–5384. doi:10.1210/endo.136.12.7588285. PMID7588285.
Egerton M, Needham M, Evans S, Millest A, Cerillo G, McPheat J, etal. (April 1995). "Identification of multiple human calcitonin receptor isoforms: heterologous expression and pharmacological characterization". Journal of Molecular Endocrinology. 14 (2): 179–189. doi:10.1677/jme.0.0140179. PMID7619207.
Nussenzveig DR, Mathew S, Gershengorn MC (May 1995). "Alternative splicing of a 48-nucleotide exon generates two isoforms of the human calcitonin receptor". Endocrinology. 136 (5): 2047–2051. doi:10.1210/endo.136.5.7720653. PMID7720653.
Nakamura M, Hashimoto T, Nakajima T, Ichii S, Furuyama J, Ishihara Y, etal. (April 1995). "A new type of human calcitonin receptor isoform generated by alternative splicing". Biochemical and Biophysical Research Communications. 209 (2): 744–751. doi:10.1006/bbrc.1995.1562. PMID7733946.
Pérez Jurado LA, Li X, Francke U (1995). "The human calcitonin receptor gene (CALCR) at 7q21.3 is outside the deletion associated with the Williams syndrome". Cytogenetics and Cell Genetics. 70 (3–4): 246–249. doi:10.1159/000134044. PMID7789182.
Kuestner RE, Elrod RD, Grant FJ, Hagen FS, Kuijper JL, Matthewes SL, etal. (August 1994). "Cloning and characterization of an abundant subtype of the human calcitonin receptor". Molecular Pharmacology. 46 (2): 246–255. PMID8078488.
Masi L, Becherini L, Gennari L, Colli E, Mansani R, Falchetti A, etal. (April 1998). "Allelic variants of human calcitonin receptor: distribution and association with bone mass in postmenopausal Italian women". Biochemical and Biophysical Research Communications. 245 (2): 622–626. doi:10.1006/bbrc.1998.8445. PMID9571205.
Christopoulos G, Perry KJ, Morfis M, Tilakaratne N, Gao Y, Fraser NJ, etal. (July 1999). "Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product". Molecular Pharmacology. 56 (1): 235–242. doi:10.1124/mol.56.1.235. PMID10385705.
Beaudreuil J, Taboulet J, Orcel P, Graulet AM, Denne MA, Baudoin C, etal. (July 2000). "Calcitonin receptor mRNA in mononuclear leucocytes from postmenopausal women: decrease during osteoporosis and link to bone markers with specific isoform involvement". Bone. 27 (1): 161–168. doi:10.1016/S8756-3282(00)00305-7. PMID10865224.
Nosaka Y, Tachi Y, Shimpuku H, Kawamura T, Ohura K (2002). "Association of calcitonin receptor gene polymorphism with early marginal bone loss around endosseous implants". The International Journal of Oral & Maxillofacial Implants. 17 (1): 38–43. PMID11858573.
"Calcitonin Receptors". IUPHAR Database of Receptors and Ion Channels. International Union of Basic and Clinical Pharmacology. Archived from the original on 2016-03-03. Retrieved 2007-07-23.